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Background:Many countries have established Food-Based Dietary Guidelines (FBDG).
For some foods, such as cheese, there is no consensus onwhether or not to include them
in these guidelines. Cheese may, however, be an excellent source of vitamin K2, which is
a macronutrient with demonstrated positive results on cardiovascular-related outcomes.
Aim: First, we assessed the role of cheese within the recently developed Lifelines
Diet Score (LLDS), a score based on the Dutch FBDG 2015 in relation to
incident cardio-metabolic diseases and all-cause mortality. Secondly, we assessed
the association of cheese intake with desphospho-uncarboxylated matrix Gla protein
(dp-ucMGP), a marker for functional vitamin K2 status, in a subset of the population.
Methods: From the Lifelines cohort study, 122,653 adult participants were included
to test the association between de LLDS and health outcomes. In a subset of 1,059
participants aged 60–75 years, dp-ucMGP levels were measured. Dietary intake was
assessed using a 110-item Food Frequency Questionnaire. Logistic regression were
applied, adjusted for relevant confounders.
Results: Median cheese intake was 23.5 [12.6–40.6] g/day. We found a positive
correlation between cheese intake and the LLDS (Spearman’s rho = 0.024, p < 0.001).
The LLDS in quintiles was associated with T2DM [OR (95% CI) Q5 (healthy diet) vs. Q1
(poor diet) = 0.54 (0.43–0.67)] and all-cause mortality [Q5 vs. Q1 = 0.62 (0.50–0.76)].
Inclusion of cheese did not alter these associations. Additionally, we found
no significant association of total cheese intake with plasma dp-ucMGP levels.
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Conclusion: In this population-based cohort study, the inclusion of cheese in the LLDS
did not change the inverse associations with incident cardio-metabolic diseases and
all-cause mortality. Furthermore, we found no significant association of total cheese
intake with plasma dp-ucMGP. The results suggest that cheese is a neutral food group
that fits a healthy diet.
Keywords: nutrition, diet, vitamin K2, cardio-metabolic diseases, all-cause mortality
INTRODUCTION
The consumption of a variety of foods is needed to support
growth, provide strength, improve cognitive function, and
reduce susceptibility to chronic diseases, illnesses, and infection
(1). To help address the nutrition concerns of populations,
many countries have established Food-Based Dietary Guidelines
(FBDG) (2). These FBDGs are expressed in terms of food and diet
rather than in nutrients, to be more easily understood and used
by community members, and are created to inform the public
about consuming a healthy diet (2). Additionally, substantial
evidence indicates that foods and dietary patterns have a stronger
influence on chronic disease risk than individual nutrients (3, 4).
In the Netherlands, the Dutch Health Council issued their
FBDG in 2015 (3). The guidelines are the result of a systematic
and critical evaluation of international peer reviewed literature
on relations of foods, dietary patterns, and nutrients with causal
risk factors and chronic disease risk. Based on the evidence
provided by the Dutch Health Council (3), a food group
classification has been made, in which groups were categorized
as positive, negative, neutral, or unknown, based on the evidence
regarding their health effects (5).
Although cheese is sometimes categorized within the food
group “dairy,” the composition of cheeses highly differs from
dairy products like milk and yogurt, resulting in e.g., differential
cardiovascular health effects (6). In the food group classification
mentioned above (5), cheese is considered to be a separate
food group with unknown health effect. Nevertheless, modest
evidence of an association between cheese intake and coronary
heart disease and stroke has previously been reported (7).
Additionally, among subjects with an impaired glycemic state at
baseline, cheese intake was found to be inversely associated with
incident diabetes, even after adjusting for BMI and other risk
factors (8).
Cheeses are often salted, contributing to high sodium intake
(6). Nevertheless, cheese is also nutrient rich, providing a wide
range of crucial vitamins (A, B6, B12, D, and K), minerals
(calcium, iodine, magnesium, potassium, phosphorus, and zinc),
fats, proteins, and other micro constituents (9, 10). Adequate
intake of these components is difficult in a diet low in dairy
(9). For example, dairy products can provide up to 60% of
the recommended daily allowance (RDA) of calcium (10).
Additionally, fermented dairy products such as cheese, are an
excellent source of fat-soluble vitamins such as vitamin K2 (11–
13), vitamin A, and vitamin E (14).
In the Netherlands, cheese is one of the food groups that
contribute substantially to the daily food intake (15, 16). In this
context it is worthwhile to further study the effect of cheese on
health outcomes. The Lifelines cohort, a large general population
cohort in the three northern provinces of the Netherlands
provides the possibility to assess the role of cheese in a healthy
diet in a large representative population. The aim of the present
study is two-fold. First, we will assess the possible role of cheese
within the recently developed Lifelines Diet Score (LLDS) (5),
a score based on the Dutch FBDG 2015. Secondly, we will
assess the association between cheese intake and desphospho-
uncarboxylated matrix Gla protein (dp-ucMGP), a marker for
functional vitamin K2 status (17) in a subset of the population,
and is considered a novel risk factor for mortality and CVD (18).
METHODS
Cohort Design and Study Population
The LifeLines cohort study is a prospective population-based
cohort study examining the health and health-related behaviors
of 167,729 persons living in the North of the Netherlands. The
overall design and rationale of the study have been described
in detail elsewhere (19, 20). Participants were included in the
study between 2006 and 2013, and written informed consent was
obtained from all participants. So far, four assessment rounds
took place [T1 = baseline, median + IQR of time in months to
follow-up rounds: T2= 13 [12-14], T3= 24 [23-27], T4= 44 [35-
51]. The Lifelines study is conducted according to the principles
of the Declaration of Helsinki and approved by the Medical
Ethics Committee of the University Medical Center Groningen,
the Netherlands.
Lifelines Population
The Lifelines cohort includes 152,662 adults (age 18–93) and
dietary information from food frequency questionnaires (FFQ)
was available for 144,095 of them. FFQ data was considered
unreliable when the ratio between reported energy intake and
basal metabolic rate, calculated with the Schofield equation
(21), was below 0.50 or above 2.75, or when energy intake
was below 800 kcal/day (males) or 500 kcal/day (females).
Fourteen thousand seven hundred and thirty-two participants
with unreliable dietary intake data were excluded, leaving 129,363
participants in the study. Furthermore, participants who self-
reported to have (had) a stroke, myocardial infarction, heart
failure, or diabetes [all types, in addition to self-reporting:
fasting glucose ≥ 7 mmol/l, HbA1c ≥ 6.5 % or medication use
(ATC A10A/A10B)] at baseline, were excluded, leaving 122,653
participants in this study (Figure S1).
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Lifelines Dp-ucMGP Sub-population
Dp-ucMGP measurements were performed in a subset of
the LifeLines population consisting of 1,600 subjects, equally
distributed over gender and socio-economic status (SES),
between 60 and 75 years of age. This subset was selected
to investigate vitamin status and subclinical micronutrient
deficiency in low vs. high socio-economic status (SES). Since
education is more differentiating than income in the Dutch
population, classification of SES was based on educational status.
Low SES was defined as never been to school or elementary
school only, or completed lower vocational or secondary
schooling; high SES was defined as completed higher vocational
schooling or education. As in the total Lifelines population,
participants with missing or unreliable dietary intake data were
excluded (n= 295) and participants who reported to have (had) a
stroke, myocardial infarction, heart failure or diabetes (all types)
at baseline (n = 201), were excluded. Furthermore, participants
reporting to use vitamin K antagonists (n = 37) were excluded
from this study, leaving 1,059 participants of this sub-cohort in
the study.
Data Collection and Measurements
Self-administered questionnaires were used to collect data
regarding demographics (education) and lifestyle (smoking,
alcohol, physical activity, diet). The validated short questionnaire
to assess health-enhancing physical activity (SQUASH) was used
to assess physical activity (22). Leisure time and Commuting
Physical activity, including sports, at moderate (4.0–6.4 MET)
to vigorous (≥6.5 MET) intensity (LC_MVPA) was calculated
in minutes per week (22). Anthropometric measurements and
blood pressure were measured by well-trained staff. BMI was
calculated as weight (kg) divided by height squared (m2).
Blood samples were collected in fasting state between 8.00 and
10.00 a.m. and subsequently transported to the Central Lifelines
Laboratory in the University Medical Center Groningen.
Functional vitamin K2 status was assessed by measuring dp-
ucMGP in EDTA plasma using a dual-antibody enzyme-linked
immunoassay [InaKtif MGP (IDS-iSYS) assay]. The lower limit
of quantitation of the InaKtif MGP assay was 300 pmol/L. Serum
creatinine (SCr) was measured via an enzymatic assay with
colorimetric detection on a Roche Modular chemistry analyzer
(Roche, Basel, Switzerland). The creatinine-based CKD-EPI
formula was used to obtain the estimated glomerular filtration
rate (eGFR) (23). Other laboratory measurements were assessed
by commercially available assays on a Roche Modular chemistry
analyzer (Roche, Basel, Switzerland).
Dietary Assessment
To assess dietary intake in the LifeLines Cohort, a 110-item semi-
quantitative baseline FFQ assessing food intake over the previous
month was developed by the Wageningen University using the
Dutch FFQTOOLTM, in which food items were selected based
on the Dutch National Food Consumption Survey of 1997/1998
(24). Energy and macronutrient intake was estimated from the
FFQ data by using the Dutch food composition database of 2011
(25). Alcohol consumers were defined as those participants who
consumed at least one alcoholic beverage in the past month.
Cheese intake was assessed with three main questions, asking
for habitual consumption of cheese on bread, bread-rolls or
crackers, with hot meals and as snack. Additionally, it was asked
what type of cheese was most frequently chosen (low fat cheese
(20/30% fat), regular high fat cheese (40/48% fat), cream cheese or
foreign cheeses (e.g., brie or blue cheese). From these data, daily
cheese intake in g/day was calculated.
The Lifelines Diet Score
The Lifelines Diet Score (LLDS) was calculated as a measure
of relative diet quality. The development of this food-based
diet score has been described in detail elsewhere (5). In
short, the LLDS is based on the scientific evidence underlying
the 2015 Dutch Dietary Guidelines, and ranks the relative
intake of nine food groups with proven positive health effects
(vegetables, fruit, whole grain products, legumes and nuts, fish,
oils and soft margarines, unsweetened dairy, coffee, and tea)
and three food groups with proven negative health effects (red
and processed meat, butter and hard margarines and sugar-
sweetened beverages) (3). For each of the food groups, quintiles
of consumption in grams/1,000 kcal are determined and awarded
zero to four points, with four points being awarded to the highest
quintile of consumption for positive food groups, and to the
lowest quintile for negative food groups. The sum of the 12
component scores resulted in a LLDS score ranging from 0
to 48. The LLDS scores were then categorized into quintiles,
with quintile 1 including 20% of participants with the lowest
diet quality and quintile 5 including 20% of participants with
the highest diet quality. As previously shown, the LLDS is
higher in women and positively associated with age category and
educational level. For men, mean LLDS ranged from 19.5 (SD
= 5.30) in males aged below 40 with low educational level, to
25.9 (SD= 5.50) in highly educated males aged 60 or higher. For
women, this range is 20.8 (SD= 5.74) to 29.1 (SD= 5.61) (5).
To investigate the role of cheese in the LLDS, cheese was
included in the LLDS as an additional, 13th group. In line with
the methods used for other food groups of the LLDS, quintiles
were made for cheese intake in grams per 1,000 kcal. Higher
scores were either awarded to the quintile of highest intake
(when cheese was considered a positive food group), or to the
quintile of lowest intake (when cheese was considered a negative
food group).
In collaboration with the National Institute for Public Health
and the Environment (RIVM), the Netherlands Nutrition Center
has calculated various diets that comply with the Dutch dietary
guidelines and with the Dietary Reference Values (26). Based
on the saturated fat and sodium dietary reference values, a
maximum for cheeses of 40 g/day has been set to fit a healthy
diet Therefore, a third approach to score cheese intake was used,
in which intake up until 40 g was scored as positive, and intake
above 40 g as negative. This resulted in four variants of the LLDS
to be investigated in statistical analyses.
Clinical End Points
In the present study, we examined associations of LLDS (with
or without cheese) with incidence of cardio-metabolic diseases
[i.e., stroke, myocardial infarction, heart failure, and type 2
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diabetes (T2DM)] and all-cause mortality. Incident cases of
stroke, myocardial infarction and heart failure were based on self-
reported questionnaires that were issued in the three follow-up
assessment rounds. Incident T2DM was defined as self-reported
T2DM according to the questionnaires in the three follow-up
rounds, or a fasting glucose ≥7.0 mmol/L or HbA1c ≥ 6.5
mmol/mol during the last follow-up assessment when blood
samples were collected. Data on prescribed medication was not
available during follow-up. Data onmortality were obtained from
the municipal register.
Statistical Analyses
Continuous data as medians with interquartile ranges (IQR)
because of the non-normal distribution of many of the
variables involved. Discrete and categorical data are presented
as frequencies (%). Logistic regression was applied to investigate
the association of cheese intake in quintiles (based on intake in
g/1,000 kcal) and incident stroke, myocardial infarction, heart
failure, T2DM and all-cause mortality. To evaluate the effect of
inclusion of cheese in the LLDS on the association of the LLDS
with clinical end points, logistic regression was applied on the
four defined LLDS (with or without cheese) and these same
five health outcomes. For cardio-metabolic health outcomes,
only participants with complete follow-up were included in
the analyses since it was unknown whether participants who
dropped-out became an incident case or not. For all-cause
mortality this does not apply, since this outcome does not rely
on self-reporting.
Furthermore, in the subset as described above, we assessed
whether cheese intake was associated with dp-ucMGP, a marker
for functional vitamin K2 status and a novel risk factor for
mortality and CVD (18). The association was investigated using
logistic regression analyses with dp-ucMGP dichotomized into
≤300 vs. >300 pmol/L as the dependent variable.
All regression analyses were adjusted for relevant confounders
including energy intake, education level, age, gender, smoking
status, alcohol intake, leisure time, and commuting moderate-
vigorous physical activity and BMI. Analyses with quintiles of
cheese intake were additionally adjusted for the regular LLDS,
and with respect to the dp-ucMGP analysis were additionally
adjusted for eGFR. Furthermore, it was tested whether gender
was an effect modifier in all regression analyses involving cheese
consumption by including the interaction-term of gender and
cheese intake in quintiles.
RESULTS
Baseline Characteristics
In the present study, we included 122,653 subjects [median age
44 (IQR 35–51) years, 40.8% male] of the adult Lifelines cohort
and 1,059 [aged 64 (62–68) years, 48.8% male] of the subset
with available dp-ucMGP data. Baseline characteristics of the
total study population and for the subpopulation with available
dp-ucMGP measurements are presented in Table 1. The median
cheese intake was 23.5 g/day in the total study population and
28.8 g/day in the subset population. The mean LLDS was 24
and 27 in the total and subset study population, respectively. We







(N = 122,653) (n = 1,059)
Demographics
Male gender (n, %) 50,101 [40.8] 513 [48.4]
Age (years) 44 [35–51] 64 [62–68]
Education
Low (%) 2.1% 40.2%
Middle (%) 66.6% -
High (%) 31.3% 59.8%
Smoking status
Never (%) 47.1% 34.8%
Former (%) 31.9% 54.0%
Current (%) 21.0% 11.2%
BMI [kg/m2] 25.3 [23.0–28.0] 25.8 [23.7–28.4]
Laboratory parameters
dp-ucMGP > 300 pmol/L (n, %) N.A. 243 [22.9%]
Total cholesterol-HDL ratio 3.38 [2.75–4.22] 3.5 [2.9–4.3]
LDL cholesterol 3.2 [2.6–3.8] 3.6 [3.0–4.2]
Triglycerides [mmol/L] 0.96 [0.7–1.36] 1.0 [0.8–1.4]
Serum creatinine [µmol/L] 72 [64–81] 74 [65–85]
eGFR [mL/min/1.73 m2 ] 98 [87–108] 84 [75–91]
Nutrition
Lifelines Diet Score [0–48] 24 [20–28] 27 [23–31]
Energy intake [kcal/day] 1985 [1636–2412] 1862 [1554–2206]
Cheese intake
Total cheese [g/day] 23.5 [12.6–40.6] 28.8 [17.5–44.2]
High fat cheese [g/day] 16.1 [5.9–32.0] 20.9 [ 7.8–39.6]
40+ cheese/cheese spread [g/day] 0 [0–10.7] 0.9 [0–14.2]
48+ cheese/cheese spread [g/day] 0 [0–6.3] 0 [0–7.1]
Cheese with hot meal [g/day] 1.1 [0–3.0] 0.9 [0–2.8]
Cheese as snack [g/day] 2.7 [0–4.6] 2.7 [0.7–5.9]
Cream cheese or foreign cheeses 0 [0–0] 0 [0–0]
[g/day]
Low fat cheese
20+/30+ cheese/cheese spread 0 [0–8.9] 0 [0–12.3]
[g/day]
found a significant correlation between daily cheese intake (in
g/day) and the LLDS (Spearman’s rho= 0.024, p < 0.001).
Cheese and Incident Stroke, Myocardial
Infarction, Heart Failure, T2DM, and
All-Cause Mortality
After a median follow-up time of 3.7 [IQR 2.9–4.3] years for
cardio-metabolic diseases, 306 (0.38%) incident cases of stroke,
325 (0.40%) incident cases of myocardial infarction, 859 (1.06%)
incident cases of heart failure, and 1,099 (1.36%) incident cases of
T2DM occurred. After a median follow-up time of 7 years [IQR
6–8] for all-cause mortality, 1,305 subjects (1.06%) had died.
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TABLE 2 | Associations of quintiles of cheese intake (based on intake in g/1,000 kcal) with cardio-metabolic diseases (N = 78,774) and all-cause mortality (N = 119,435).






































































































Q1 (low cheese intake) was used as reference quintile.
Models are adjusted for: energy intake, education level, age, gender, smoking status, alcohol intake, moderate-vigorous physical activity and BMI, and additionally for diet quality (LLDS).
The association of cheese intake with incident cardio-
metabolic diseases is depicted in Table 2 and Figure 1 (upper
panel). Cheese intake was not associated with incident cardio-
metabolic diseases, adjusted for relevant confounders [OR
(95%CI) for Q5 (healthy diet) vs. Q1 (poor diet) = 1.08
(0.71 – 1.63) for stroke, 1.10 (0.77–1.58) for myocardial
infarction, 1.26 (0.99–1.62) for heart failure and 1.12 (0.91–
1.38) for T2DM]. In addition, the associations of the LLDS
with incident cardio-metabolic diseases in which cheese is
not included in the score (regular LLDS), as a negative or
positive food group, or using a 40 g/day cut-off to define
cheese as a positive or negative food group are also shown
in Figure 1. In multivariable analysis, higher scores on the
regular LLDS were associated with a modest, borderline
significant, decrease in the risk for myocardial infarction
[OR (95% CI) Q5 vs. Q1= 0.69 (0.47–1.02), P = 0.056], and a
substantial and significant decrease in risk for T2DM [0.54
(0.43–0.67), P < 0.001] and all-cause mortality [0.62 (0.50–
0.76), P < 0.001]. The inclusion of cheese either as a positive or
negative food group in the LLDS resulted in an attenuation of
the borderline association of the LLDS andmyocardial infarction,
while the inverse associations with T2DM and all-cause mortality
remained statistically significant, independent on how cheese
was introduced in the score. Inclusion of cheese defined by
the 40 g/day cut-off did not affect the associations with cardio-
metabolic diseases.
The association of cheese and the different LLDS with
all-cause mortality is depicted in Figure 2. Adjusted for relevant
confounders, cheese was not associated with all-cause mortality
[0.94 (0.78–1.14)]. The inclusion of cheese in the LLDS, either as
a positive or negative food group, or when applying the 40 g/day
cut-off, did not result in a different association with all-cause
mortality compared to the regular LLDS. All types of LLDS
were significantly inversely associated with all-cause mortality.
None of the associations between cheese intake and health were
modified by gender.
Cheese Intake and Dp-ucMGP
The association between cheese intake and dp-ucMGP was
assessed in a subset of 1,059 Lifelines participants. A total
of 816 participants (77.1%) had a plasma dp-ucMGP level
under the detection level of 300 pmol/L. We found no
significant association between cheese intake in g/day and
plasma dp-ucMGP levels (Spearman’s rho = 0.032, p =
0.304). However, when investigating the association in 243
participants with dp-ucMGP levels above the detection level
of 300 pmol/L, a non-significant but negative association was
found (Spearman’s rho=−0.029, p = 0.656). The association
between cheese intake, presented for quintiles of cheese intake,
and plasma dp-ucMGP levels is depicted in Table 3. We found
no significant trend across these quintiles (p for trend = 0.193).
Also in confounder adjusted logistic regression, no significant
association between cheese intake in quintiles and having a dp-
ucMGP above 300 pmol/L was found (p = 0.093) (Table 4).
Furthermore, the association was not modified by gender.
DISCUSSION
In this study in the general population, the LLDSwas significantly
associated with a lower risk of T2DM and all-cause mortality.
Inclusion of cheese intake in the LLDS did not alter the
associations compared to the regular LLDS. In an elderly subset
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FIGURE 1 | (A–D) Associations of quintiles of cheese intake (based on intake in g/1,000 kcal) with cardio-metabolic diseases (N = 78,774). Low cheese intake or Q1
of the LLDS as reference. Adjusted for: energy intake, diet quality (LLDS), education level, age, gender, smoking status, alcohol intake, moderate-vigorous physical
activity, and BMI.
of the population we investigated whether cheese intake was
associated with plasma dp-ucMGP level. We found no significant
association of total cheese intake with plasma dp-ucMGP levels.
Our findings are in line with current literature. There is
no scientific consensus on the health effects of cheese (27–
29). In the present study the absence of an association with
health outcomes may be the result of the exclusion of high risk
individuals, but may also be explained by the observation that
cheese was consumed by those who had a relatively healthy
diet (30). However, the association between cheese and health
outcomes did not differ in models with and without adjustment
of diet quality (LLDS).
The absence of an significant association of cheese with
health outcomes may be the result of cheese being a relative
“balanced” food with both healthy and less healthy components.
While cheese is one of the major sources of saturated fat, which
potentially increases plasma levels of low-density lipoprotein-
cholesterol (LDL-C) (31), it has also a high content of calcium,
which binds with fatty acids in the intestine to form insoluble
soap leading to reduced absorption of fat, promoting a higher
excretion of fecal fat (32). The both potential positive and
negative effects of cheese consumption have been previously
been observed with respect to blood lipids (33–35), and may
well-explain the largely unchanged associations of the LLDS with
and without cheese with clinical end points in the present study.
In the current study, for the regular LLDS we found no
association with cardiovascular diseases. This may be due to the
relatively low incidence—and hence low discriminative power-in
this population with an average age at baseline of 44 years, but
also be the result of the exclusively self-reported data that defined
these health outcomes. This, in contrast to T2DM and all-cause
mortality for which laboratory parameters or municipal register
data was available.
Since it has been shown that cheese is the richest source of
long-chain menaquinones (vitamin K2) in the Western diet (36),
it would be expected that higher cheese intake is associated with
lower dp-ucMGP levels. We could, however, not detect such an
association in the total sample of participants with measured dp-
ucMGP. The absence of this association may be related to the
high lower limit of quantification of the dp-ucMGP assay (i.e.,
300 pmol/L), as in the small subgroup of participants above this
lower limit, an inverse association between cheese intake and
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dp-ucMGP was found, although not significant. Additionally,
it should be noted, however, that actual vitamin K2 content
varies considerably and relies on the type of cheese, the time of
ripening, the fat content and the region where the cheeses are
produced (12). Since the vitamin K2 content varies substantially
between different types of cheese, total cheese intake may not
be an accurate marker for actual vitamin K2 intake. Given the
unavailability of more specific and detailed data on cheese intake
FIGURE 2 | Associations of quintiles of cheese intake (based on intake in
g/1,000 kcal) with all-cause mortality (N = 119,435). Low cheese intake or Q1
of the LLDS as reference. Adjusted for: energy intake, diet quality (LLDS),
education level, age, gender, smoking status, alcohol intake,
moderate-vigorous physical activity, and BMI.
(i.e., exact type of cheese and time of ripening) in this study
population, we were not able the assess the association of intake
of different types of cheese with dp-ucMGP levels or adjust
for intake of different types of cheese in analyses. Furthermore,
although it has been suggested that vitamin K2 is more effective
in activating extra-hepatic vitamin K-dependent proteins than
vitamin K1 (16), vitamin K1 also contributes to vitamin K2 status
(37). In the present study, intake of vitamin K1 (mainly from
green vegetables) may also have contributed to dp-ucMGP levels.
Some limitations of the present study need to be addressed.
First, dietary intake was based on self-reported data, and are
subject to recall bias. Second, given the lower limit of quantitation
of the dp-ucMGP assay (i.e., 300 pmol/L), this assay may not be
sensitive enough to detect effects of cheese intake in the LifeLines
study population in which 77% of the subjects had dp-ucMGP
levels <300 pmol/L. In addition, the cross-sectional design may
not have been the most appropriate for testing the association of
cheese intake and plasma dp-ucMGP levels, as it is not possible
to fully adjust and account for factors affecting plasma dp-
ucMGP levels. Intervention studies may be more appropriate to
investigate the effect of cheese intake on dp-ucMGP levels. For
example, Dalmeijer et al. demonstrated that plasma dp-ucMGP
concentrations decreased significantly and dose-dependently
after 12 weeks of menaquinone supplementation (38).
Major strengths of the present study are the large sample
size, prospective design, long-term follow-up and the availability
of data on many potential confounding factors. Furthermore,
median daily cheese intake in the dp-ucMGP sub-cohort (28.8
g/day) is highly comparable to the estimated intake in the
adult Dutch population (29.0 g/day). As expected, the evidence
based LLDS shows clear dose-response associations with health
outcomes like T2DM and all-cause mortality, which adds to the
validity of the score as a measure of relative diet quality. The
TABLE 3 | Cheese intake (median [range]) and number of participants with dp-ucMGP >300 pmol/L across quintiles of daily cheese intake.












Cheese intake in g/day [median (range)] 6 (0–10) 16 (10-19) 24 (19-29) 39 (29-44) 64 (45–161)
Dp-ucMGP > 300 pmol/L [n (%)] 23 (16.4%) 44 (26%) 49 (21.3%) 64 (24.6%) 63 (24.2%) 0.193
TABLE 4 | Logistic regression analysis to investigate the association of cheese intake quintile (g/day) and the odds of having a dp-ucMGP > 300 pmol/L.































Models 1: Adjusted for energy intake, education level, age, gender, smoking status, alcohol intake, moderate-vigorous physical activity, and BMI. Models 2: adjusted for model 1 + diet
quality (LLDS).
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absence of a clear (dose-response) association of the LLDS with
stroke, myocardial infarction and heart failure may be related to
a lower data quality for these cardiovascular health outcomes.
In contrary to T2DM and al-cause mortality, the identification
of incident cases for these three cardiovascular outcomes relied
solely on self-reporting.
In conclusion, in this population based cohort study, the
intake of cheese was not associated with cardio-metabolic health
outcomes or all-cause mortality and we found no significant
association of total cheese intake with plasma dp-ucMGP.
Furthermore, the inclusion of cheese in the LLDS did not change
the inverse associations with T2DM and all-cause mortality
compared to the LLDS without cheese. Therefore, the results
suggest that cheese is a neutral food that fits a healthy diet.
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